drugset / Trial / NCT05802810
The Mass Balance Study of [14C]JT001
NaSingle-groupOpen-labelTreatment
Summary
This study is a single center, single dose, non-randomized, open design clinical study.By quantitative analysis of the biological samples of subjects after oral administration of \[14C\]JT001, the data of human radioactive excretion rate and the main excretion pathway will be obtained. The main metabolites ,metabolic pathways and elimination pathways of JT001 will be identified.
Timeline
- Start
- 2023-03-18
- Primary completion
- 2023-09-27
- Completion
- 2023-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JT001 | Small molecule | 100 unknown | Oral |
| Subject | JT001 | Small molecule | 300 mg | Oral |
Indications
No indication recorded.